Overview of Dr. Bange
Dr. Erin Bange is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 3 years. She is one of 495 doctors at Memorial Sloan Kettering Cancer Center and one of 90 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 10 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2017 - 2019
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2016
Certifications & Licensure
- FL State Medical License 2022 - Present
- CT State Medical License 2024 - 2025
- NJ State Medical License 2022 - 2025
- NY State Medical License 2022 - 2025
- PA State Medical License 2016 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 340 citationsCD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer.Erin Bange, Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma
Nature Medicine. 2021-05-20 - 56 citationsImpact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non–Small-Cell Lung CancerErin Bange, Melina E. Marmarelis, Wei-Ting Hwang, Yu-Xiao Yang, Jeffrey C. Thompson
JCO Precision Oncology. 2019-05-10 - 27 citationsOpportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal AdenocarcinomaErin Bange, Abigail Doucette, Peter Gabriel, Florence Porterfield, James J Harrigan
JCO Oncology Practice. 2020-03-04
Press Mentions
- Most People with Cancer Respond Well to COVID-19 VaccinesJune 18th, 2021
- Virus Doesn’t Threaten U.S. Blood SupplyJune 3rd, 2021
- Higher CD8 T Cells May Influence COVID-19 Recovery in Blood Cancer PatientsMay 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: